Clinical Trial Update: Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 bioavailability and pharmacokinetics study of the investigational drug FDL169 completed in healthy subjects and individuals with cystic fibros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• FDL169

Snippet

Sponsor: Flatley Discovery Lab LLC | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED